Mechelen, Belgium; 23 July 2013 - Galapagos NV (Euronext: GLPG) announced today
the achievement of a late stage discovery milestone for small molecules against
a novel target in the osteoarthritis (OA) alliance with Servier. This milestone
triggered a payment to Galapagos of ?3 millio ...
↧